Form 8-K - Current report:
SEC Accession No. 0001104659-24-080852
Filing Date
2024-07-18
Accepted
2024-07-18 16:40:13
Documents
13
Period of Report
2024-07-17
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2419653d1_8k.htm   iXBRL 8-K 25144
  Complete submission text file 0001104659-24-080852.txt   197903

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA alms-20240717.xsd EX-101.SCH 3009
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE alms-20240717_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alms-20240717_pre.xml EX-101.PRE 22355
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2419653d1_8k_htm.xml XML 3679
Mailing Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 650-231-6625
ALUMIS INC. (Filer) CIK: 0001847367 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42143 | Film No.: 241125189
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)